Four organizations launch a new hub to support innovative AMR solutions for Biopharma Companies
BIOASTER, Cynbiose, ICTA, and PharmaLex announced a strategic collaboration that aims to help combat antimicrobial resistance.
Read moreEmglev Therapeutics – new member
Emglev is a unique synthetic single domain antibodies company dedicated to discover and develop transformative immunotherapies
Read moreAMKbiotech – new member
AMKbiotech is a CRO providing the biomedical actors with a specialized expertise and tailored services in high-plex spatial biology and cytometry for biomarker identification and treatment efficacy validation.
Read moreValerio Therapeutics – new member
Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions.
Read moreETAP-Lab annonce l’acquisition de SYNCROSOM
10 Octobre 2023 – ETAP-Lab, société de recherche sur contrat (CRO) préclinique spécialisée en Neurologie et Dermatologie, annonce l’acquisition de SYNCROSOME (PACA), CRO préclinique spécialisée dans les pathologies cardio-pulmonaires. Cette acquisition marque une étape significative dans l’évolution d’ETAP-Lab et renforce sa position en tant que CRO préclinique de premier plan. En savoir plus
Read more